These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35725165)

  • 1. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy.
    Hou X; Zhong D; Chen H; Gu Z; Gong Q; Ma X; Zhang H; Zhu H; Luo K
    Carbohydr Polym; 2022 Sep; 292():119662. PubMed ID: 35725165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
    Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
    Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.
    Rao NV; Yoon HY; Han HS; Ko H; Son S; Lee M; Lee H; Jo DG; Kang YM; Park JH
    Expert Opin Drug Deliv; 2016; 13(2):239-52. PubMed ID: 26653872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review.
    Zhang R; Zhao X; Jia A; Wang C; Jiang H
    Int J Biol Macromol; 2023 Sep; 249():125993. PubMed ID: 37506794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy.
    Safdar MH; Hussain Z; Abourehab MAS; Hasan H; Afzal S; Thu HE
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1967-1980. PubMed ID: 29082766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy.
    Kim K; Choi H; Choi ES; Park MH; Ryu JH
    Pharmaceutics; 2019 Jun; 11(7):. PubMed ID: 31262049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.
    Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G
    Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
    Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
    Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress in Carrier-Free Nanomedicine for Tumor Phototherapy.
    Zhong YT; Cen Y; Xu L; Li SY; Cheng H
    Adv Healthc Mater; 2023 Feb; 12(4):e2202307. PubMed ID: 36349844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
    Zhang Y; Li J; Pu K
    Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
    Gao M; Deng H; Zhang W
    Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer therapy mediated by nanomedicines.
    Zhang S; Zhang H; Song P; Wang D; Wang Y
    Chem Commun (Camb); 2023 Apr; 59(30):4423-4435. PubMed ID: 36950975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors.
    Fathi M; Abdolahinia ED; Barar J; Omidi Y
    Nanomedicine (Lond); 2020 Sep; 15(22):2171-2200. PubMed ID: 32912045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
    Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
    Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances and clinical translation of liposomal delivery systems in cancer therapy.
    Chen J; Hu S; Sun M; Shi J; Zhang H; Yu H; Yang Z
    Eur J Pharm Sci; 2024 Feb; 193():106688. PubMed ID: 38171420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.